Institute for International Research

IIR is pleased to provide conference delegates with access to all presentations that the presenters have permitted us to distribute. Only paid conference delegates have permission to access IIR online documentation.

You will need the freely available Adobe Acrobat Reader, which is available by clicking here. 

---

Amaravadi, Lakshmi
Drug Tolerance in Preclinical and Clinical Immunogenicity Assays - Regulatory and Study Design Considerations

Baker, Matthew
Ex vivo T cell assays for pre-clinical assessment of immunogenicity

Baltrukonis, Daniel
Technical Challenges and Regulatory Expectations for Assessing Immunogenicity to a Biotherapeutic Mimetic

Bourdage, Jim
Comparisons of Drug Tolerance for Multiple Immunogenicity Formats

Coffey, Todd
A Statistical Comparison of Methods for Determining Screening Cutpoints for Immunogenicity Assays 

Goyal, Jaya
Clinical Impact of (Neutralizing) Anti-Drug Antibody Development

Gunn, George
Transgenic Mice as a Model for Immunogenicity Screening

Kwok, Bill
Uses of HLA peptide binding assay to determine whether a peptide has a potential of being immunogenic

Lerner, Michaela
IFNb Neutralizing Antibodies Assays Titer Comparability

Loyet, Kelly
Neutralizing Antibody Assay Comparisons for ATA Characterization

Marsden, Robin
The Development and Validation of an Electrochemiluminescence Assay to Detect Antibodies to an Endogenous Protein Therapeutic

Shaw, Eric
Recombinant Human Albumin (rHA) Used in M-M-RTM II Vaccine

Stas, Philippe
File 1 - Immunogenicity Assesment of Therapeutic Proteins
File 2 - Immunogenicity screening in protein drug development

Tovey, Michael G.
Characterization of Neutralizing Antibodies to Interferons Using a Novel Cell-Based Assay

Verthelyi, Daniela
Thinking about Immunogenicity: From Tolls to packaging

Wakshull, Eric
Immunogenicity Assay Interference from Soluble Drug Targets 

Wensel, David
Screening Assay Development and Validation

Zuckerman, Linda
Immunogenicity Assay Platform for IL-21